Vitestro
Develops autonomous robotic phlebotomy devices for diagnostic blood collection
$70MSeries B
Role not disclosedLV
Labcorp Venture Fund
labcorp.com ↗Activity from announced rounds
Activity in this selectionAI
Labcorp Venture Fund invests in healthcare innovation, including diagnostic technologies, platforms and services.
Investment focus
The fund works with founders developing more data-driven and personalized care. Its focus on diagnostic innovation links new technologies with clinical and healthcare-delivery needs.
Activity recorded by RoundOS
In RoundOS, Vitestro develops robotic diagnostic blood collection, Prenosis builds critical-care diagnostic technology, and N-Power Medicine connects community oncology with clinical research and data services. These recorded financings provide examples of healthcare activity; the list does not claim to cover the fund’s full portfolio.
Sources
- Rounds participated in
- 4
- Confirmed lead rounds
- — 4 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $98M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionPrenosis
Develops integrated diagnostics and therapeutics for critical care conditions
$20MSeries A
Role not disclosedBIOMAKERS
BIOMAKERS analyzes clinical and genomic information.
$8MUndisclosed
Role not disclosedIMVARIA
Develops AI-based digital biomarkers to support clinical diagnosis.
UndisclosedStrategic
Role not disclosed